Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway

Autor: Hao Liu, Zhong-Lian Li, Xi-Bo Zhang, Yan-Li Wu
Rok vydání: 2019
Předmět:
Male
Obstructive jaundice
Decoction
Apoptosis
Liver injury
B cell lymphoma/leukemia-2 gene
Yinchenhao decoction
CCAAT/enhancer-binding protein homologous protein
Cell Line
03 medical and health sciences
eIF-2 Kinase
0302 clinical medicine
Liver Function Tests
Proto-Oncogene Proteins
medicine
Animals
Rats
Wistar

Protein kinase A
bcl-2-Associated X Protein
Kinase
Chemistry
Endoplasmic reticulum
Gastroenterology
Growth arrest and DNA damage-inducible protein 34
RNA
General Medicine
Basic Study
medicine.disease
Endoplasmic Reticulum Stress
Antigens
Differentiation

Culture Media
Rats
Jaundice
Obstructive

Liver
Proto-Oncogene Proteins c-bcl-2
030220 oncology & carcinogenesis
Cancer research
Hepatocytes
030211 gastroenterology & hepatology
Protein kinase RNA-like endoplasmic reticulum kinase
B cell lymphoma/leukemia-2 gene related X protein
Hepatocyte apoptosis
Transcription Factor CHOP
Drugs
Chinese Herbal
Zdroj: World Journal of Gastroenterology
ISSN: 2219-2840
Popis: BACKGROUND Chronic biliary obstruction results in ischemia and hypoxia of hepatocytes, and leads to apoptosis. Apoptosis is very important in regulating the homeostasis of the hepatobiliary system. Endoplasmic reticulum (ER) stress is one of the signaling pathways that induce apoptosis. Moreover, the protein kinase RNA-like endoplasmic reticulum kinase (PERK)-induced apoptotic pathway is the main way; but its role in liver injury remains unclear. Yinchenhao decoction (YCHD) is a traditional Chinese medicine formula that alleviates liver injury and apoptosis, yet its mechanism is unknown. We undertook this study to investigate the effects of YCHD on the expression of ER stress proteins and hepatocyte apoptosis in rats with obstructive jaundice (OJ). AIM To investigate whether YCHD can attenuate OJ-induced liver injury and hepatocyte apoptosis by inhibiting the PERK-CCAAT/enhancer-binding protein homologous protein (CHOP)-growth arrest and DNA damage-inducible protein 34 (GADD34) pathway and B cell lymphoma/leukemia-2 related X protein (Bax)/B cell lymphoma/leukemia-2 (Bcl-2) ratio. METHODS For in vivo experiments, 30 rats were divided into three groups: control group, OJ model group, and YCHD-treated group. Blood was collected to detect the indicators of liver function, and liver tissues were used for histological analysis. For in vitro experiments, 30 rats were divided into three groups: G1, G2, and G3. The rats in group G1 had their bile duct exposed without ligation, the rats in group G2 underwent total bile duct ligation, and the rats in group G3 were given a gavage of YCHD. According to the serum pharmacology, serum was extracted and centrifuged from the rat blood to cultivate the BRL-3A cells. Terminal deoxynucleotidyl transferase mediated dUTP nick end-labelling (TUNEL) assay was used to detect BRL-3A hepatocyte apoptosis. Alanine aminotransferase (ALT) and aspartate transaminase (AST) levels in the medium were detected. Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) analyses were used to detect protein and gene expression levels of PERK, CHOP, GADD34, Bax, and Bcl-2 in the liver tissues and BRL-3A cells. RESULTS Biochemical assays and haematoxylin and eosin staining suggested severe liver function injury and liver tissue structure damage in the OJ model group. The TUNEL assay showed that massive BRL-3A rat hepatocyte apoptosis was induced by OJ. Elevated ALT and AST levels in the medium also demonstrated that hepatocytes could be destroyed by OJ. Western blot or qRT-PCR analyses showed that the protein and mRNA expression levels of PERK, CHOP, and GADD34 were significantly increased both in the rat liver tissue and BRL-3A rat hepatocytes by OJ. The Bax and Bcl-2 levels were increased, and the Bax/Bcl-2 ratio was also increased. When YCHD was used, the PERK, CHOP, GADD34, and Bax levels quickly decreased, while the Bcl-2 levels increased, and the Bax/Bcl-2 ratio decreased. CONCLUSION OJ-induced liver injury and hepatocyte apoptosis are associated with the activation of the PERK-CHOP-GADD34 pathway and increased Bax/Bcl-2 ratio. YCHD can attenuate these changes.
Databáze: OpenAIRE